Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-22

FDA Approved: FULVESTRANT — Original Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

The FDA approved Glenmark Pharmaceuticals' generic fulvestrant for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)